Literature DB >> 2174724

Increased cell division as a cause of human cancer.

S Preston-Martin1, M C Pike, R K Ross, P A Jones, B E Henderson.   

Abstract

Carcinogenesis research is increasingly focused on chemicals that are not genotoxic and yet, at high doses, can induce cancer, apparently by increasing cell proliferation. We hypothesize that increased cell division per se stimulated by external or internal factors is also associated with the development of many human cancers. Although this hypothesis is well substantiated in the experimental literature, it has not been generalized as an important mechanism for carcinogenesis in human populations. Under this increased cell division model, the pathogenesis of cancer may result from molecular genetic errors induced during the process of cell division and from altered growth control of malignant or premalignant cells. Molecular genetic analysis of human cancers has shown that tumor cells contain multiple genetic defects including mutations, translocations, and amplifications of oncogenes and are reduced to homozygosity for putative tumor suppressor genes; these phenomena all require cell division for their occurrence and fixation. Increased cell division increases the risk of such events occurring. An accumulation of a combination of such genetic errors leads to a neoplastic phenotype. Examples are discussed of human cancers in which increased cell division, which drives the accumulation of genetic errors and can lead to neoplastic transformation, is caused by hormones, drugs, infectious agents, chemicals, physical or mechanical trauma, and other chronic irritation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174724

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  158 in total

1.  Dietary fibre and the risk of colorectal cancer.

Authors:  R A Goodlad
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Arguments in editorial were not "biologically implausible".

Authors:  K McPherson
Journal:  BMJ       Date:  1999-07-03

3.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

4.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

Review 5.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

6.  Influence of calorie restriction on oncogene expression and DNA synthesis during liver regeneration.

Authors:  Y Himeno; R W Engelman; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

7.  Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.

Authors:  Sarit Ben-Shmuel; Eyal J Scheinman; Rola Rashed; Zila Shen Orr; Emily J Gallagher; Derek LeRoith; Ran Rostoker
Journal:  J Endocrinol       Date:  2015-09-17       Impact factor: 4.286

Review 8.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 9.  Stem cell chronicles: autobiographies within genomes.

Authors:  Darryl Shibata; Simon Tavaré
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

Review 10.  Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.

Authors:  Sara K Story; Michael K Schowalter; Larisa J Geskin
Journal:  Oncologist       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.